TNF and inflammatory bowel disease: We found that patients with IBD on immunosuppressive therapies, primarily TNF blockers, produce lower amounts of S1-RBD antibodies, neutralizing antibodies, and antibody-secreting plasmablasts after mRNA vaccination than healthy controls.